Enter Note Done

Session


Steven R Steinhubl, Jill Waalen, Scripps Res Translational Inst, Lajolla, CA; Anirudh Sanyal, Alison M Edwards, Healthagen, Chicago, IL; Lauren M Ariniello, Gail S Ebner, Katie Baca-Motes, Scripps Res Translational Inst, Lajolla, CA; Robert A Zambon, Janssen Pharmaceuticals, Titusville, NJ; Troy Sarich, Johnson & Johnson, New Brunswick, NJ; Eric J. J Topol, Scripps Res, La Jolla, CA
Disclosure Block: S.R.Steinhubl: Other; Modest; DynoSense, EasyG, Livongo, Otsuka, Research Grant; Significant; Janssen. E.J.Topol: None. J.Waalen: None. A.Sanyal: Employment; Significant; Healthagen Outcomes. A.M.Edwards: Employment; Significant; Healthagen, part of the CVS Health family of companies. L.M.Ariniello: None. G.S.Ebner: None. K.Baca-motes: None. R.A.Zambon: Employment; Significant; Janssen R&D. T.Sarich: Employment; Significant; Johnson & Johnson, Stock Shareholder; Significant; Johnson & Johnson.
Communities
Health & Wellness
Prevention
Session Types
Late-Breaking Science
Featured Sessions
Yes
Science Types
Population Science